Logo image of ALAUD.PA

AUDACIA SA (ALAUD.PA) Stock Fundamental Analysis

EPA:ALAUD - FR00140059B5 - Common Stock

3.68 EUR
0 (0%)
Last: 9/5/2025, 7:00:00 PM
Fundamental Rating

4

Taking everything into account, ALAUD scores 4 out of 10 in our fundamental rating. ALAUD was compared to 112 industry peers in the Capital Markets industry. While ALAUD seems to be doing ok healthwise, there are quite some concerns on its profitability. ALAUD is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year ALAUD was profitable.
ALAUD had a negative operating cash flow in the past year.
In the past 5 years ALAUD has always been profitable.
In multiple years ALAUD reported negative operating cash flow during the last 5 years.
ALAUD.PA Yearly Net Income VS EBIT VS OCF VS FCFALAUD.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M

1.2 Ratios

ALAUD's Return On Assets of 2.73% is fine compared to the rest of the industry. ALAUD outperforms 66.07% of its industry peers.
Looking at the Return On Equity, with a value of 5.05%, ALAUD is in line with its industry, outperforming 48.21% of the companies in the same industry.
The Return On Invested Capital of ALAUD (1.61%) is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for ALAUD is significantly below the industry average of 8.38%.
Industry RankSector Rank
ROA 2.73%
ROE 5.05%
ROIC 1.61%
ROA(3y)1.63%
ROA(5y)4.1%
ROE(3y)3.1%
ROE(5y)10.26%
ROIC(3y)2.17%
ROIC(5y)3.73%
ALAUD.PA Yearly ROA, ROE, ROICALAUD.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

ALAUD has a Profit Margin (5.22%) which is comparable to the rest of the industry.
ALAUD's Profit Margin has declined in the last couple of years.
ALAUD has a Operating Margin (3.19%) which is comparable to the rest of the industry.
ALAUD's Operating Margin has declined in the last couple of years.
Industry RankSector Rank
OM 3.19%
PM (TTM) 5.22%
GM N/A
OM growth 3Y-42%
OM growth 5Y-29.1%
PM growth 3Y-50.47%
PM growth 5Y-16.29%
GM growth 3YN/A
GM growth 5YN/A
ALAUD.PA Yearly Profit, Operating, Gross MarginsALAUD.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

More info and screens

4

2. Health

2.1 Basic Checks

ALAUD has more shares outstanding than it did 1 year ago.
The number of shares outstanding for ALAUD has been increased compared to 5 years ago.
ALAUD has a worse debt/assets ratio than last year.
ALAUD.PA Yearly Shares OutstandingALAUD.PA Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M
ALAUD.PA Yearly Total Debt VS Total AssetsALAUD.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

An Altman-Z score of 2.11 indicates that ALAUD is not a great score, but indicates only limited risk for bankruptcy at the moment.
ALAUD's Altman-Z score of 2.11 is fine compared to the rest of the industry. ALAUD outperforms 66.07% of its industry peers.
A Debt/Equity ratio of 0.04 indicates that ALAUD is not too dependend on debt financing.
ALAUD has a better Debt to Equity ratio (0.04) than 83.04% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Altman-Z 2.11
ROIC/WACCN/A
WACCN/A
ALAUD.PA Yearly LT Debt VS Equity VS FCFALAUD.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 5M 10M

2.3 Liquidity

ALAUD has a Current Ratio of 1.39. This is a normal value and indicates that ALAUD is financially healthy and should not expect problems in meeting its short term obligations.
ALAUD has a better Current ratio (1.39) than 70.54% of its industry peers.
A Quick Ratio of 1.38 indicates that ALAUD should not have too much problems paying its short term obligations.
ALAUD's Quick ratio of 1.38 is fine compared to the rest of the industry. ALAUD outperforms 72.32% of its industry peers.
Industry RankSector Rank
Current Ratio 1.39
Quick Ratio 1.38
ALAUD.PA Yearly Current Assets VS Current LiabilitesALAUD.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 192.41% over the past year.
Measured over the past years, ALAUD shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -20.30% on average per year.
The Revenue has grown by 20.41% in the past year. This is a very strong growth!
ALAUD shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.76% yearly.
EPS 1Y (TTM)192.41%
EPS 3Y-45.98%
EPS 5Y-20.3%
EPS Q2Q%344.79%
Revenue 1Y (TTM)20.41%
Revenue growth 3Y17.06%
Revenue growth 5Y-0.76%
Sales Q2Q%16.07%

3.2 Future

ALAUD is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 55.81% yearly.
The Revenue is expected to grow by 16.77% on average over the next years. This is quite good.
EPS Next Y-26.09%
EPS Next 2Y35.13%
EPS Next 3Y55.81%
EPS Next 5YN/A
Revenue Next Year4.62%
Revenue Next 2Y11.63%
Revenue Next 3Y16.77%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALAUD.PA Yearly Revenue VS EstimatesALAUD.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5M 10M 15M 20M
ALAUD.PA Yearly EPS VS EstimatesALAUD.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 33.45 indicates a quite expensive valuation of ALAUD.
Compared to the rest of the industry, the Price/Earnings ratio of ALAUD is on the same level as its industry peers.
The average S&P500 Price/Earnings ratio is at 27.06. ALAUD is valued slightly more expensive when compared to this.
With a Price/Forward Earnings ratio of 21.02, ALAUD is valued on the expensive side.
Based on the Price/Forward Earnings ratio, ALAUD is valued a bit cheaper than 65.18% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.69, ALAUD is valued at the same level.
Industry RankSector Rank
PE 33.45
Fwd PE 21.02
ALAUD.PA Price Earnings VS Forward Price EarningsALAUD.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALAUD.PA Per share dataALAUD.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2 2.5

4.3 Compensation for Growth

ALAUD's earnings are expected to grow with 55.81% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.13%
EPS Next 3Y55.81%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALAUD!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AUDACIA SA

EPA:ALAUD (9/5/2025, 7:00:00 PM)

3.68

0 (0%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.59%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap18.40M
Analysts84.44
Price Target10 (171.74%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-56.41%
EPS NY rev (3m)-56.41%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-19.05%
Valuation
Industry RankSector Rank
PE 33.45
Fwd PE 21.02
P/S 1.41
P/FCF N/A
P/OCF N/A
P/B 1.37
P/tB 1.64
EV/EBITDA N/A
EPS(TTM)0.11
EY2.99%
EPS(NY)0.18
Fwd EY4.76%
FCF(TTM)-0.13
FCFYN/A
OCF(TTM)-0.09
OCFYN/A
SpS2.61
BVpS2.69
TBVpS2.24
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.73%
ROE 5.05%
ROCE 2.9%
ROIC 1.61%
ROICexc 2.3%
ROICexgc 2.94%
OM 3.19%
PM (TTM) 5.22%
GM N/A
FCFM N/A
ROA(3y)1.63%
ROA(5y)4.1%
ROE(3y)3.1%
ROE(5y)10.26%
ROIC(3y)2.17%
ROIC(5y)3.73%
ROICexc(3y)3.12%
ROICexc(5y)6.64%
ROICexgc(3y)4.16%
ROICexgc(5y)7.27%
ROCE(3y)3.82%
ROCE(5y)6.52%
ROICexcg growth 3Y-44.1%
ROICexcg growth 5Y-25.27%
ROICexc growth 3Y-48.5%
ROICexc growth 5Y-28.87%
OM growth 3Y-42%
OM growth 5Y-29.1%
PM growth 3Y-50.47%
PM growth 5Y-16.29%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 1.44%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.39
Quick Ratio 1.38
Altman-Z 2.11
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)11.7%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)192.41%
EPS 3Y-45.98%
EPS 5Y-20.3%
EPS Q2Q%344.79%
EPS Next Y-26.09%
EPS Next 2Y35.13%
EPS Next 3Y55.81%
EPS Next 5YN/A
Revenue 1Y (TTM)20.41%
Revenue growth 3Y17.06%
Revenue growth 5Y-0.76%
Sales Q2Q%16.07%
Revenue Next Year4.62%
Revenue Next 2Y11.63%
Revenue Next 3Y16.77%
Revenue Next 5YN/A
EBIT growth 1Y-38.69%
EBIT growth 3Y-32.11%
EBIT growth 5Y-29.63%
EBIT Next Year250%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-5.79%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-196.9%
OCF growth 3YN/A
OCF growth 5YN/A